Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
about
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney DiseaseRole of Myeloperoxidase in Patients with Chronic Kidney DiseaseNitric oxide synthase derangements and hypertension in kidney diseaseApproaches to uremiaOxidative stress and nucleic acid oxidation in patients with chronic kidney diseaseUsing the cytokinesis-block micronucleus cytome assay to evaluate chromosomal DNA damage in chronic renal patients undergoing bicarbonate haemodialysis and haemodiafiltrationMolecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.Safety of intravenous iron in hemodialysis patients.Evaluation of objective and subjective indicators of death in a period of one year in a sample of prevalent patients under regular hemodialysis.Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise.An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.Biology of sepsis: its relevance to pediatric nephrology.Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan.p-Cresol affects reactive oxygen species generation, cell cycle arrest, cytotoxicity and inflammation/atherosclerosis-related modulators production in endothelial cells and mononuclear cells.Circulating dendritic cell precursors in chronic kidney disease: a cross-sectional study.Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.Plasma and urinary heme oxygenase-1 in AKI.Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney diseaseMalondialdehyde can predict survival in hemodialysis patientsOxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol - Differences or Similarities?The assessment of oxidative stress on patients with chronic renal failure at different stages and on dialysis patients receiving different hypertensive treatmentThe Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention.Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome?Vascular damage in kidney disease: beyond hypertension.Inflammation, vitamin D and dendritic cell precursors in chronic kidney disease.Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease.Klotho Prevents NFκB Translocation and Protects Endothelial Cell From Senescence Induced by Uremia.CKD and Risk for Hospitalization With Infection: The Atherosclerosis Risk in Communities (ARIC) Study.Febuxostat for hyperuricemia in patients with advanced chronic kidney diseaseAssociation of elevated frequency of micronuclei in peripheral blood lymphocytes of type 2 diabetes patients with nephropathy complications.Wishful Thinking: The Surprisingly Sparse Evidence for a Relationship between Oxidative Stress and Cardiovascular Disease in Hemodialysis Patients.Blood thiol status and erythrocyte glutathione-S-transferase in chronic kidney disease patients on treatment with frequent (daily) hemodialysis.Prevalence of depression and suicidal ideation increases proportionally with renal function decline, beginning from early stages of chronic kidney disease.The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients.Plasma cysteine/cystine reduction potential correlates with plasma creatinine levels in chronic kidney disease.Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature.
P2860
Q26740125-77032790-8F12-4967-B298-4C7BF3C0E81AQ26748996-0ADCEEC2-118A-4A81-957E-24626B2E3D04Q26849234-B361D093-B6FD-407B-A293-E1CED3210A21Q26864807-18B2548C-2843-4055-A67A-C7D8444D40B5Q27006908-77C60D89-B9C1-4D4D-AACF-8D10E32DE1DFQ28074187-4A6360F7-7C85-42E5-BF57-2F8C9A32DB44Q30234751-24D62D8C-97D2-4924-BB00-25FC589022A2Q30234981-7120D6E7-6BDE-4C6D-AD9A-EE859FE477B3Q31044690-DC12FA7F-EDF5-43F0-8D60-8C5CD06EA492Q33630922-3847E9AD-DB76-42A6-98CF-70B7A8911520Q33663437-4718C5AB-E541-4E64-AB94-F3AFA8974F9FQ33882451-DFAEFC37-DFE1-4845-9C98-9E1A94D43D5DQ34549739-B48E21EC-2716-43D5-BB3B-46314D1583E6Q34724151-41597FE8-ADA3-4E5F-BB01-64C0EEC4FB2DQ35064431-7989D0F5-5DF3-4DB0-A509-87A1A1072AADQ35715691-FAD2ADE3-3FD3-43DC-A00D-85787D458983Q35818228-8DF2CFE7-2921-4ECE-A764-BB32FF672521Q35982380-4A393C58-D614-4780-B57E-8709D45B4504Q36605539-22FA9977-56BD-4006-BD0F-80FB48E97841Q36808315-3B551666-C0EE-4E4F-8BF0-9BEA6C955D11Q36824691-2B2B515B-D1B6-4E7D-8C72-F78846A12096Q36848131-4230B471-3686-4406-9A07-EFFB942487AAQ37041316-CFE1A601-B822-43CE-9FE1-0F9071F99623Q37199405-9090DF60-783A-4D80-85CF-F3604EDD8FFCQ37495847-DAC556AA-17EE-4712-A582-B3E93FD121AEQ37837005-F5B12E28-8715-45E7-A621-995957EBE67AQ37899201-32F957DC-371D-436F-8FC6-2254E65D78CEQ38256997-7E33E082-B6BF-4E9C-A666-292FFD32F963Q38842023-C4A97DA1-57A0-42D6-A115-80BAD8D89684Q38912908-085F31B9-11CF-4F32-80CB-248535725EEBQ38954111-AD147F1D-6D76-4CC4-B462-3FE4F8D0F9E6Q39156032-DD156ACE-0C21-45C7-AF61-4D777206171BQ42268534-440DA60A-0228-4371-B986-558BF5B93CC3Q42495174-AE259108-0E3A-4C95-B995-700A954CB135Q44916889-9BA33A47-C21F-48C4-82C4-225A6C60566AQ46173596-0C87F056-7F0D-4BB1-BC0A-DBE9FAC56077Q47097274-BE46477A-5767-4B00-8108-345D3030F567Q47848978-C9BB47E7-7D3C-47A2-B1E4-A45E5ED3FA5AQ51300666-1A4F42C3-4759-4A92-BCE3-F92DDE42CFFCQ55228680-10E9EB46-17F6-4F11-880C-C159BAACF1B7
P2860
Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
@en
Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
@nl
type
label
Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
@en
Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
@nl
prefLabel
Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
@en
Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
@nl
P2860
P1433
P1476
Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
@en
P2093
Jonathan Himmelfarb
P2860
P304
P356
10.1111/J.1525-139X.2009.00659.X
P577
2009-11-01T00:00:00Z